Lv3
206 积分 2022-04-20 加入
TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
1个月前
已关闭
Antibody Modification via Lipoic Acid Ligase A‐Mediated Site‐Specific Labeling
2个月前
已完结
Antibody Modification via Lipoic Acid Ligase A‐Mediated Site‐Specific Labeling
2个月前
已完结
皖公网安备34019202002308
